Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States

IMPORTANCE: In 2005, the US Advisory Committee on Immunization Practices recommended routine quadrivalent meningococcal conjugate (MenACWY) vaccine for all adolescents aged 11 to 12 years, and in 2010, a booster dose for adolescents aged 16 years. Measuring the association between MenACWY vaccinatio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Pediatr
Main Authors: Mbaeyi, Sarah, Pondo, Tracy, Blain, Amy, Yankey, David, Potts, Caelin, Cohn, Amanda, Hariri, Susan, Shang, Nong, MacNeil, Jessica R.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372499/
https://ncbi.nlm.nih.gov/pubmed/32687590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.1990
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares